BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial

Media coverage

• Title	TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients
  Media name/outlet	News-Medical.Net
  Country/Territory	Australia
  Date	31/03/20
  URL	https://www.news-medical.net/news/20200330/TWILIGHT-trial-Brilinta-reduces-bleeding-compared-to-dual-therapy-in-high-risk-coronary-patients.aspx
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.biospace.com/article/releases/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial-/?s=86
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Global Banking & Finance Review
  Country/Territory	United Kingdom
  Date	30/03/20
  URL	https://www.globalbankingandfinance.com/category/news/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial/
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Maryville Daily Times
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.thedailytimes.com/business/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary/article_ac784ad1-c05b-5482-92c3-8170287498ad.html
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Market Newsdesk
  Country/Territory	United States
  Date	30/03/20
  URL	www.marketnewsdesk.com/?p=240094
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Crwe World
  Country/Territory	United States
  Date	30/03/20
  URL	crweworld.com/article/news-provided-by-business-wire/1473055/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Jotup
  Country/Territory	United States
  Date	30/03/20
  URL	https://jotup.co/node/713841
  Persons	Roxana Mehran,

• Title	ACC.20/WCC: Ticagrelor Reduced Bleeding Vs Dual Therapy in High-Risk Coronary Patients in Sub-Analyses From Phase IV TWILIGHT Trial
  Media name/outlet	Cath Lab Digest
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.cathlabdigest.com/content/acc20wcc-ticagrelor-reduced-bleeding-vs-dual-therapy-high-risk-coronary-patients-sub-analyses-phase-iv-twilight-trial
  Persons	Roxana Mehran,

• Title	Brilinta Monotherapy Shown to Reduce Bleeding in High-Risk Patients
  Media name/outlet	PharmiWeb
  Country/Territory	United Kingdom
  Date	30/03/20
  URL	https://www.pharmiweb.com/press-release/2020-03-30/brilinta-monotherapy-shown-to-reduce-bleeding-in-high-risk-patients
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Cardiac Vascular News
  Country/Territory	United States
  Date	30/03/20
  URL	cardiacvascularnews.com/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial/
  Persons	Roxana Mehran,

• Title	Brilinta reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	CompanyNewsHQ
  Country/Territory	United Kingdom
  Date	30/03/20
  URL	https://www.companynewshq.com/company-news/pharmaceutical-company-news/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial/
  Persons	Roxana Mehran,

• Title	Brilinta reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial 30 March 2020
  Media name/outlet	AstraZeneca
  Country/Territory	United Kingdom
  Date	30/03/20
  URL	https://www.astrazeneca.com/media-centre/press-releases/2020/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial.html
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	CIT
  Country/Territory	United States
  Date	30/03/20
  URL	www.businesswire.com/news/home/20200330005412/en/BRILINTA-reduced-bleeding-dual-therapy-high-risk-coronary/
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Tullahoma News
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.tullahomanews.com/news/business/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary/article_e6e4d876-df6a-5fbb-aac1-03bf69eea736.html
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Citizen Tribune
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.citizentribune.com/news/business/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary/article_71b8a907-1c67-5538-870b-f206faf6c4f1.html
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Herald Chronicle
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.heraldchronicle.com/news/business/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary/article_c7c0ecdc-baab-5509-bee4-32671966caa5.html
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Manchester Times
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.manchestertimes.com/news/business/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary/article_4654426c-ddfd-5a2f-bf7b-555e6edd698e.html
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Elk Valley Times
  Country/Territory	United States
  Date	30/03/20
  URL	https://www.elkvalleytimes.com/news/business/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary/article_906160e0-5416-5ff4-8f02-16af0430b3a0.html
  Persons	Roxana Mehran,

• Title	Brilinta reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	PressReleasePoint
  Country/Territory	India
  Date	30/03/20
  URL	https://www.pressreleasepoint.com/brilinta-reduced-bleeding-vs-dual-therapy-high-risk-coronary-patients-sub-analyses-phase-iv-twilight
  Persons	Roxana Mehran,

• Title	BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
  Media name/outlet	Digital Media Net
  Country/Territory	United States
  Date	30/03/20
  URL	dmnnewswire.digitalmedianet.com/2020/03/30/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial/?utm_source=rss&utm_medium=rss&utm_campaign=brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial
  Persons	Roxana Mehran,